← Back to Search

Procedure

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery (DoD FAI-2 Trial)

Madison, WI
N/A
Waitlist Available
Led By John C Clohisy, MD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre operative (baseline), change from baseline promis - a at 3 months, change from baseline promis - a at 6 months, change from baseline promis - a at 1 year, and change from baseline promis - a at 2 year
Awards & highlights
No Placebo-Only Group

Summary

The overarching goal of the study is to improve the surgical treatment outcomes of FAI, which is affecting an increasing number of military personnel and young active individuals in the general population. The proposed study will investigate critical patient, disease, and surgical treatment predictors of FAI surgery outcomes.

See full description
Eligible Conditions
  • Femoroacetabular Impingement

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre operative (baseline), change from baseline promis - pf at 3 months, change from baseline promis - pf at 6 months, change from baseline promis -pf at 1 year, and change from baseline promis - pf at 2 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre operative (baseline), change from baseline promis - pf at 3 months, change from baseline promis - pf at 6 months, change from baseline promis -pf at 1 year, and change from baseline promis - pf at 2 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hip disability and Osteoarthritis Outcome Score (HOOS)
Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety (A)
Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression (D)
+4 more
Secondary study objectives
Brief Resilience Scale (BRS)
International Hip Outcome Tool (iHot-12)
Mobility, Stability, and Pain (MSP Question)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Closest Location:University of Michigan· Ann Arbor, MI· 165 miles

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
2,022 Previous Clinical Trials
2,351,435 Total Patients Enrolled
San Antonio Military Medical CenterFED
21 Previous Clinical Trials
4,039 Total Patients Enrolled
William Beaumont HospitalsOTHER
152 Previous Clinical Trials
112,142 Total Patients Enrolled
Boca Raton Regional HospitalOTHER
2 Previous Clinical Trials
423 Total Patients Enrolled
Boston Children's HospitalOTHER
796 Previous Clinical Trials
5,582,899 Total Patients Enrolled
CHU de Quebec-Universite LavalOTHER
176 Previous Clinical Trials
109,194 Total Patients Enrolled
Mayo ClinicOTHER
3,416 Previous Clinical Trials
3,208,612 Total Patients Enrolled
Twin Cities OrthopedicsOTHER
3 Previous Clinical Trials
127 Total Patients Enrolled
Regents of the University of MichiganUNKNOWN
2 Previous Clinical Trials
1,412 Total Patients Enrolled
Ottawa Hospital Research InstituteOTHER
583 Previous Clinical Trials
3,280,750 Total Patients Enrolled
~72 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top